Categories: CancerHealthcareNews

4baseCare Secures CAP Accreditation, Elevating Genomic Profiling Standards for Cancer Patients in the UAE

BENGALURU, India , March 17, 2025 /PRNewswire/ — 4baseCare, a leader in precision oncology, has achieved a major milestone with CAP (College of American Pathologists) accreditation for its genomics lab at Dubai Science Park, established in partnership with Innovate Life Sciences Fz-LLC. This accreditation ensures that cancer patients in the UAE now have access to world-class genomic profiling locally, meeting the highest international standards of quality and accuracy.

By securing CAP accreditation, 4baseCare reaffirms its commitment to advancing cancer care through data-driven, personalized treatment decisions. The Dubai-based facility bridges a critical gap in precision oncology, eliminating the need for patients to seek genomic testing solutions outside of the UAE .

“Our mission is to democratize access to high-quality genomic insights, empowering oncologists with cutting-edge molecular data to drive better patient outcomes,” said Dr. Sudharshan Elangovan, VP of Global Operations, 4baseCare.

Syed Hussaini, General Manager, Innovate Life Sciences, added, “This achievement underscores our dedication to quality and innovation, strengthening our mission to make precision medicine more accessible and affordable across the Middle East and beyond.”

About 4baseCare

An Illumina Accelerator company backed by Infosys Innovation Fund, 4baseCare pioneers precision oncology solutions through advanced genomics and digital health technology. 4baseCare boasts of a stellar advisory board which includes Lip Bu Tan (CEO, Intel Corporation), Francis deSouza (COO, Google Cloud and ex-CEO Illumina) and Prof George Church (Professor, Harvard Medical School).

With CAP accreditation, the company further cements its position as a trusted global partner in precision oncology, supporting healthcare providers in delivering targeted and effective cancer treatments.

Linkedin page: 4baseCare

Video: https://mma.prnewswire.com/media/2642650/4baseCare_Secures_CAP_Accreditation.mp4

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/4basecare-secures-cap-accreditation-elevating-genomic-profiling-standards-for-cancer-patients-in-the-uae-302402841.html

SOURCE 4baseCare

Staff

Recent Posts

Apollo Neuroscience Announces 2025 Year in Review

Community Gains Nearly 144 Million Minutes of Sleep, Wins Best Sleep Wearable of 2025NEW YORK,…

3 hours ago

Paytient Recognized by Modern Healthcare for Transforming Patient Experience

COLUMBIA, Mo., Jan. 30, 2026 /PRNewswire/ -- Paytient, a leader in innovative healthcare affordability and…

3 hours ago

Promino Announces Closing of Private Placement

Burlington, Ontario--(Newsfile Corp. - January 30, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC:…

7 hours ago

NuGen Medical Devices Inc. Announces CFO Transition

Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

9 hours ago

Midmark RTLS launches BLE Sensory Network for smarter, scalable RTLS

New Plug-In BLE Sensors provide a faster, more cost-effective path to facility-wide RTLS coverage with near-room…

9 hours ago

Vrtly, Inc. Unveils End-to-End In-Practice Marketing Platform, Bridging the “Blind Spot” for Brands in Cash-Pay Healthcare

DANVILLE, Calif., Jan. 30, 2026 /PRNewswire/ -- Vrtly, Inc., the premier point-of-care (POC) marketing platform…

9 hours ago